Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice

Abstract

BACKGROUND: To investigate the comparative effectiveness of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) on cardiovascular outcomes in routine clinical practice, which have never been directly compared in head-to-head outcome trials. METHODS: We compared outcomes of adults who newly started SGLT2i or GLP1-RA therapy in Stockholm, Sweden, during 2013-2019. The primary outcome was …

Authors

Fu EL; Clase CM; Janse RJ; Lindholm B; Dekker FW; Jardine MJ; Carrero J-J

Journal

International Journal of Cardiology, Vol. 352, , pp. 172–179

Publisher

Elsevier

Publication Date

4 2022

DOI

10.1016/j.ijcard.2022.01.042

ISSN

0167-5273

Associated Experts

Catherine Clase

Professor, Faculty of Health Sciences

Visit profile

Labels